Aristeidis Grigoriadis

Aristeidis Grigoriadis

CLINTEC, Karolinska Institutet, Stockholm, Sweden
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2021 in European Radiology
Verified
Journal Article
Closed access
PDF file
SVSudhakar Venkatesh
Sudhakar Venkatesh
CWChristopher L. Welle
Christopher L. Welle
FMFrank H. Miller
Frank H. Miller
KJKartik Jhaveri
Kartik Jhaveri
KRKristina I. Ringe
Kristina I. Ringe
IPIpscsg
Ipscsg

23 April 2015 in European Radiology
Verified
Journal Article
Closed access
PDF file
MFMichael A. Fischer
Michael A. Fischer
NKNikolaos Kartalis
Nikolaos Kartalis
AGAristeidis Grigoriadis
Aristeidis Grigoriadis
LLLouiza Loizou
Louiza Loizou
PSPer I Stål
Per I Stål
TBTorkel B. Brismar
Torkel B. Brismar

1 September 2021 in European Journal of Radiology
Verified
Journal Article
Open access
AGAristeidis Grigoriadis
Aristeidis Grigoriadis
KRKristina I. Ringe
Kristina I. Ringe
MAMats Andersson
Mats Andersson
NKNikolaos Kartalis
Nikolaos Kartalis
ABAnnika Bergquist
Annika Bergquist
ANALI-scores are two prognostic magnetic resonance imaging (MRI)-based scores developed for patients with primary sclerosing cholangitis (PSC). Our study aims to assess the interreader agreement between expert radiologists of the two ANALI-scores and of the radiological parameters they utilize, and to test the prognostic performance of the scores in our population. Three radiologists evaluated MRIs of 98 PSC-patients from a prospectively collected cohort with median follow-up of 6.7 years. Each parameter of ANALI-scores was assessed, and the scores were calculated. Interreader agreement was assessed with intraclass correlation coefficient (ICC). After consensus reading was reached, the prognostic value of ANALI-scores was assessed with Cox regression, and outcome-free survival rates were evaluated with Kaplan-Meier estimates. The ANALI-score without gadolinium had poor to moderate (ICC = 0.56, 95 %CI: 0.42-0.68) and with gadolinium poor (ICC = 0.30, 95 %CI: 0.16-0.44) agreement. Liver deformity (ICC = 0.28, 95 %CI: 0.13-0.44) and parenchymal enhancement heterogeneity (ICC = 0.24, 95 %CI: 0.12-0.38) had poor agreement. Portal hypertension had poor to moderate (ICC = 0.48, 95 %CI: 0.36-0.59) and dilatation of the intrahepatic ducts had moderate (ICC = 0.64, 95 %CI: 0.54-0.73) agreement. Hazard ratios for liver-related death, transplantation or cirrhosis decompensation of the ANALI-scores with and without gadolinium were 3.53 (95 %CI: 1.40-8.93) and 2.25 (95 %CI: 1.56-3.24), respectively. Outcome-free survival was better for patients with low ANALI-scores. The ANALI-scores show poor to moderate agreement, which challenges their usefulness in clinical practice. They are associated with clinical outcomes, confirming the value of imaging in prognosis of PSC, but need further multicenter evaluation.

22 September 2022 in JHEP Reports
Verified
Journal Article
Open access
AGAristeidis Grigoriadis
Aristeidis Grigoriadis
KRKristina Imeen Ringe
Kristina Imeen Ringe
JBJohan Bengtsson
Johan Bengtsson
EFErik Baubeta Fridh
Erik Baubeta Fridh
CFCecilia Forsman
Cecilia Forsman
ABAnnika Bergquist
Annika Bergquist
Magnetic resonance cholangiopancreatography (MRCP) is used for the diagnosis and follow-up of individuals with primary sclerosing cholangitis (PSC). The aim of our study is to develop an MRCP-score based on cholangiographic findings previously associated with outcomes and assess its reproducibility and prognostic value in PSC. The score (DiStrict score) was developed based on the extent and severity of cholangiographic changes of intrahepatic and extrahepatic bile ducts (range 0–8) on 3D-MRCP. In this retrospective, multicentre study, three pairs of radiologists with different levels of expertise from three tertiary centres applied the score independently. MRCP examinations of 220 consecutive individuals with PSC from a prospectively collected PSC-cohort, with median follow-up of 7.4 years, were reviewed. Inter-reader and intrareader agreements were assessed via intraclass correlation coefficient (ICC). After consensus, the prognostic value of the score was assessed using Cox-regression and outcome-free survival rates were assessed via Kaplan-Meier estimates. Harrell's C-statistic was calculated. Forty patients developed outcomes (liver transplantation or liver-related death). Inter-reader agreement between experienced radiologists was good (ICC 0.82; 95% CI 0.74–0.87, and ICC 0.81; 95% CI 0.70–0.87, respectively) and better than the agreement for the pair of experienced/less-experienced radiologists (ICC 0.48; 95% CI 0.05–0.72). Agreement between radiologists from the three centres was good (ICC 0.76; 95% CI 0.57–0.89). Intrareader agreement was good to excellent (ICC 0.85–0.93). Harrell's C was 0.78. Patients with a DiStrict score of 5–8 had 8.2-fold higher risk (hazard ratio 8.2; 95% CI 2.97–22.65) of developing outcomes, and significantly worse survival (p <0.001), compared to those with a DiStrict score of 1–4. The novel DiStrict score is reproducible and strongly associated with outcomes, indicating its prognostic value for individuals with PSC in clinical practice. The diagnosis of primary sclerosing cholangitis (PSC) is based on magnetic resonance cholangiopancreatography (MRCP). However, the role of MRCP in the prognostication of PSC is still unclear. We developed a novel, simple, and reproducible risk-score, based on MRCP findings, that showed a strong association with prognosis in individuals with PSC (DiStrict score). This score can be easily used in clinical practice and thus has the potential to be useful in clinical trials and in patient counselling and management.

1 August 2020 in European Journal of Radiology
Verified
Journal Article
Closed access
KRKristina I. Ringe
Kristina I. Ringe
ABAnnika Bergquist
Annika Bergquist
HLHenrike Lenzen
Henrike Lenzen
NKNikolaos Kartalis
Nikolaos Kartalis
MMMichael P. Manns
Michael P. Manns
AGAristeidis Grigoriadis
Aristeidis Grigoriadis

1 February 2020 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Open access
AGAristeidis Grigoriadis
Aristeidis Grigoriadis
FMFabian Morsbach
Fabian Morsbach
NVNikolaos Voulgarakis
Nikolaos Voulgarakis
KSKarouk Said
Karouk Said
ABAnnika Bergquist
Annika Bergquist
NKNikolaos Kartalis
Nikolaos Kartalis
Objectives: Interpretation of MRI/MRCP in primary sclerosing cholangitis (PSC) at a single time point has low inter-reader agreement. Agreement of interpretation of the dynamic course of duct changes in follow-up MRI/MRCP is of clinical importance but remains unknown. Our aims are therefore to assess the inter-reader agreement of interpretation of the course of duct changes in PSC and investigate if elimination of 3 D MRCP affects inter-reader agreement. Materials and Methods: We studied 40 consecutive PSC-patients who underwent two liver MRI/MRCPs at two time points. Two readers independently evaluated the course of duct changes between the two time points in two imaging sets, one with and one without 3 D MRCP. The intraclass correlation coefficient (ICC) was calculated for evaluation of inter-reader and intra-reader agreement between the two time points and two imaging sets accordingly. Results: Inter-reader agreement of the interpretation of the course of duct changes between the two time points was poor (ICC up to 0.224). Elimination of 3 D MRCP neither improved inter-reader agreement which was again poor (ICC up to 0.26) nor did it change considerably the way readers interpret the course of ducts changes (ICC for intra-reader agreement between 0.809 and 0.978). Conclusions: Inter-reader agreement of the interpretation of radiological course of duct changes is poor in serial follow-up MRI/MRCP of PSC-patients. Elimination of 3 D MRCP does not increase inter-reader agreement but maintains an excellent intra-reader agreement for the interpretation of the dynamic course of bile duct changes.